GLAXOSMITHKLINE PLC

GSK

Delayed - 04/15 11:35:28 am
1348.4GBX	+4.56%

Turn to zoom

Prev.	1289.6000
Open	1285.6000
High	1388.4000
Low	1269.0890
Volume	21 234 212

8h ago	FTSE 100 ends higher on GlaxoSmithKline boost; midcaps at record highs
9h ago	GlaxoSmithKline Up Over 5%, on Pace for Largest Percent Increase in Over a...
9h ago	European ADRs Move Higher in Thursday Trading
10h ago	Vir Biotechnology : GlaxoSmithKline's COVID-19 Drug Candidate Under...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bearish
Resistance	1 367	1 468	1 414
Spread/Res.	-1,4%	-8,1%	-4,6%
Spread/Supp.	5,5%	13%	13%
Support	1 278	1 191	1 191

Sales 2021	33 651 M 46 380 M 46 380 M
Net income 2021	3 807 M 5 247 M 5 247 M
Net Debt 2021	21 383 M 29 471 M 29 471 M
P/E ratio 2021	17,4x
Yield 2021	5,90%

Capitalization	67 183 M 92 611 M 92 596 M
EV / Sales 2021	2,63x
EV / Sales 2022	2,47x
Nbr of Employees	94 066
Free-Float	92,5%

GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (50%): intended for respiratory diseases (64.9% of net sales), HIV infection (28.6%), immune system disorders (4.3%) ) and cancer (2.2%);
- OTC and...

>> Read more

Sector :

Other Pharmaceuticals

Calendar :

2021-04-28 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	HOLD
Number of Analysts	27
Average target price	1 516,25 GBX
Last Close Price	1 348,40 GBX
Spread / Highest target	52,0%
Spread / Average Target	12,4%
Spread / Lowest Target	-28,5%